Genomic Research in Alpha-1 Antitrypsin Deficiency
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Becich, MD, PhD
University of Pittsburgh
Principal Investigator - Naftali Kaminski, MD
Yale University
Principal Investigator - Stephen Wisniewski, PhD
University of Pittsburgh
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arizona Health Sciences Center
Tucson, Arizona, United States
- University of California - San Francisco
San Francisco, California, United States
- National Jewish Health
Denver, Colorado, United States
- Yale University
New Haven, Connecticut, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
- University of Pittsburgh
Pittsburgh, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- Vanderbilt University
Nashville, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2013
- Primary completion
- 30 Jun 2015
- Completion
- 30 Sept 2015
- Last update posted
- 12 Jan 2016
- Registered enrollment
- 140
- Registry id
- NCT01832220
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.